DiaMedica Therapeutics Inc. (DMAC) financial statements (2021 and earlier)

Company profile

Business Address 2 CARLSON PARKWAY
MINNEAPOLIS, MN 55447
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:28817
Cash and cash equivalents7417
Short-term investments204 
Other undisclosed cash, cash equivalents, and short-term investments 0 
Receivables011
Prepaid expense  0
Deposits current assets00 
Other undisclosed current assets00 
Total current assets:28918
Noncurrent Assets
Operating lease, right-of-use asset00
Property, plant and equipment000
Deposits noncurrent assets  0
Total noncurrent assets:000
TOTAL ASSETS:28918
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:211
Accounts payable  0
Employee-related liabilities000
Other undisclosed accounts payable and accrued liabilities110
Debt000
Other undisclosed current liabilities0  
Total current liabilities:211
Noncurrent Liabilities
Long-term debt and lease obligation000
Finance lease, liability00
Capital lease obligations0
Operating lease, liability00
Other undisclosed noncurrent liabilities(0)  
Total noncurrent liabilities:000
Total liabilities:211
Stockholders' equity
Stockholders' equity attributable to parent26817
Additional paid in capital956463
Accumulated other comprehensive income (loss)(0)0 
Accumulated deficit(69)(57)(46)
Total stockholders' equity:26817
TOTAL LIABILITIES AND EQUITY:28918

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit:  1
Operating expenses(13)(12)(7)
Operating loss:(13)(12)(7)
Nonoperating income011
Other nonoperating income (expense)00(0)
Loss from continuing operations before income taxes:(12)(11)(6)
Income tax expense(0)(0)(0)
Net loss available to common stockholders, diluted:(12)(11)(6)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(12)(11)(6)
Comprehensive loss:(12)(11)(6)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0 
Comprehensive loss, net of tax, attributable to parent:(12)(11)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: